offer
all report title image
  • Published On : Jun 2022
  • Code : CMI1267
  • Industry : Advanced Materials
  • Pages : 130
  • Formats :

Microcrystalline cellulose is refined wood pulp and chemically inert substance, extensively used in food, pharmaceuticals, cosmetic, and polymer composite industries. This is, owing to its non-toxicity, renewability, biodegradability, and mechanical properties such as high surface area and bio compatibility.  In processed food products, it is used as an emulsifier, stabilizer, anti-caking agent, texture modifier, stabilizer, fat substitute, and suspending agent.  

Microcrystalline Cellulose market was valued at US$ 1,029.2 Million in 2021 in terms of revenue, exhibiting a CAGR of 6.7% during the forecast period (2022 to 2030).

Drivers

Increasing application of microcrystalline cellulose in various industries is a major factor propelling growth of the global microcrystalline cellulose market. For instance, microcrystalline cellulose is used as stabilizer, gelling agent, suspending agent, and anti-caking agent in beverages. It is also used as a cold and hot stabilizer, in frozen food, ice cream, and canned meat, in order to improve the shelf life of these products. Furthermore, MCC (Microcrystalline Cellulose) is widely used in pharmaceuticals, owing to its tastelessness, odorlessness, and chemical inertness properties. According to the International Trade Administration, in 2021, the global market for pharmaceuticals is projected to grow from around US$ 1.22 trillion in 2021 to US$ 1.42 trillion by 2021. Steadily growing pharmaceutical industry is expected to support market growth of microcrystalline cellulose over the forecast period.

Among regions, North America held the dominant position, in terms of revenue, in the global microcrystalline cellulose market in 2021, and accounted for a market share of 30.47%. This is attributed to steadily growing food and pharmaceutical industries as microcrystalline cellulose has high demand in pharmaceuticals and is extensively used as functional ingredient in food and beverages. Moreover, increasing demand for low fat food, owing to growing obese population in the region is a factor expected to support growth of market over the forecast period. This is because MCC is gaining popularity as a cellulose-based fat replacer and is widely used in sauces, dairy products, salad dressings, and frozen desserts.

Figure 1. Global Microcrystalline Cellulose Market Value Share (%), By Region, 2021

Microcrystalline Cellulose  | Coherent Market Insights

Market Restraints

Lack of universal directives pertaining to applications of microcrystalline cellulose is expected to restrain market growth during the forecast period. Every country has different directives pertaining to use and applications of microcrystalline cellulose. Key players find it difficult to cope with such country wise regulations, which in turn is discouraging investment in the Microcrystalline Cellulose industry, thereby restraining market growth.

CMI table icon

Microcrystalline Cellulose Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: 1,029.2 Mn
Historical Data for: 2017-2021 Estimated Year: 2022
Forecast Period 2022 to 2030 CAGR: 6.7% Forecast Period: 2022-2030
Geographies covered:
  • Region: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa
Segments covered:
  • By Source Type: Wood Based, Non-wood Based
  • By End-use Industry: Pharmaceutical, Food & Beverages, Cosmetics & Personal Care, Others
Companies covered:

Huzhou City Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma, Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei Corporation, Dupont, Avantor Inc., Sigachi Industries Pvt. Ltd, Foodchem International Corporation, Quadra Chemicals, Maple Biotech Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., Accent Microcell Pvt. Ltd., RanQ, and Chemfield Cellulose

Growth Drivers:
  • Increasing application of microcrystalline cellulose in various industries is a major factor propelling growth of the global microcrystalline cellulose market  
  • Increasing disposable income in emerging economies is propelling the growth of food & beverages & pharmaceutical industry, which is in turn boosting demand for microcrystalline cellulose  
Restraints & Challenges:
  • Lack of universal directives pertaining to use and applications of microcrystalline cellulose is one of the major factor restraining growth of market

Market Trends

Increasing disposable income of people and their growing awareness about health is propelling growth of food & beverages and pharmaceuticals  industries in emerging economies and in various sub regions such as China, India, South Africa, Indonesia, Brazil, The Association of Southeast Asian Nations (ASEAN) etc. Thus, expanding pharmaceuticals and food & beverages in industries is expected to boost demand for microcrystalline cellulose, which in turn is expected to boost growth of market.

Figure 2. Global Microcrystalline Cellulose Market Value Share (%), By End Use Industry, 2021

Microcrystalline Cellulose  | Coherent Market Insights

Among end use industry, pharmaceutical segment accounted for a dominant share in market in 2021, owing to high use of microcrystalline cellulose in pharmaceutical. This is due to its chemical inertness and dry binding properties. Furthermore, food and beverage segment is expected to exhibit a substantial growth in the global microcrystalline cellulose market over the forecast period. This is due to wide application of micro crystalline cellulose in various food and beverages including desserts, frozen food, dairy products, and baked goods.  In addition to this, it is also used as a fat replacer and helps maintain food consistency.  

Global Microcrystalline Cellulose Market - Impact of Coronavirus (COVID-19) Pandemic

Market was negatively impacted by the effect of COVID-19 pandemic. Major manufactures of microcrystalline cellulose such as MC Corporation, Asahi Kasei Corporation, Juku Orchem Private Limited and Mingtai Chemical Co. Ltd. operating in market have their manufacturing & supply chain facilities across the globe. These players had halted production of microcrystalline cellulose in first and second wave of COVID 19 due to lowered demand, lockdown measures, supply chain bottlenecks, and to protect the safety of their employees.  

Recent Developments

  • On 1 June 2022, Asahi Kasei Medical has completed its acquisition of Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant contract manufacturing services to biopharmaceutical companies. Bionova Scientific will operate as a business unit within Asahi Kasei Medical’s bioprocess division. Bionova Scientific will continue to expand its business by building on its strengths as a CDMO specialized in the process design and manufacture of various types of biologics such as microcrystalline cellulose, cytokines, vaccines, hormones etc.
  • In May 2022, Asahi Kasei had established a group-wide data management platform called “DEEP” (Data Exploration and Exchange Pipeline) to accelerate digital transformation (DX) throughout the Asahi Kasei Group, and started its operation in April 2022. DEEP has already been utilized in the analysis of several businesses, and is expected to make further contribution to the enhancement of management and businesses.
  • In January 2021, Asahi Kasei's specialty solutions SBU had announced that they will build a second plant for microcrystalline cellulose at its Mizushima Works in Kurashiki, Okayama, Japan. The expansion is expected to be completed by 2023’s spring season. Asahi Kasei currently manufactures Ceolus, a microcrystalline cellulose used primarily in pharmaceuticals as tablet binder, in Nobeoka, Miyazaki, Japan. Through this expansion Asahi Kasei will enhance its market presence in Japan and adjoining countries.

Competitive Section

Major players operating in the global Microcrystalline Cellulose market include Huzhou City Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma, Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei Corporation, Dupont, Avantor Inc., Sigachi Industries Pvt. Ltd, Foodchem International Corporation, Quadra Chemicals, Maple Biotech Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., Accent Microcell Pvt. Ltd., RanQ, and Chemfield Cellulose.

Microcrystalline Cellulose Market Size and Forecast to 2030

Cellulose is an organic substance, with high content of fiber. It is extensively used in packaged food products, in order to enhance their shelf life and to enhance their nutritional value. Pure cellulose is available in market in various forms such as microcrystalline cellulose (MCC), powdered cellulose (PC), and low crystallinity powdered cellulose (LCPC). The difference between various forms of cellulose is related to the size, shape and degree of crystallinity of their particles. Microcrystalline cellulose (MCC) is largely gaining popularity and is used extensively in the pharmaceutical sector. It is a purified and partly depolymerized cellulose with shorter crystalline polymer chains. MCC is widely used as a binder and filler in drug formulations, owing to its strong binding performance.  In addition to this, microcrystalline cellulose is also useful in the food & beverages and cosmetics & personal care industries.

 

 

Market Dynamics

Development of new grades of microcrystalline cellulose  with improved pharmaceutical characteristics including silicified microcrystalline cellulose (SMCC) and second generation MCC grades, is expected to increase its penetration in the pharmaceutical industry, and support market growth of microcrystalline cellulose. Further, the wide applicability of microcrystalline cellulose is considered as another factor, driving growth of market. Microcrystalline cellulose is widely used in packaged food as a texturizing and anti-caking agent and is also used in cosmetics and personal care products such as hair and skin care products.

 

North America held a dominant position in the global microcrystalline cellulose market in 2021, owing to growing pharmaceutical industry in the region. According to the European Federation of Pharmaceutical Industries and Associations, in 2021, North America accounted for the largest share in the world pharmaceutical market with 48.5% share. Low calorie food is gaining popularity among obese population in the region, which is expected to support market growth, as microcrystalline cellulose is majorly used as a cellulose based fat replacer in dairy products, sauces, and frozen desserts.

 

Key features of the study:

  • This report provides an in-depth analysis of global microcrystalline cellulose market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global microcrystalline cellulose market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Huzhou City Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma, Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei Corporation, Dupont, Avantor Inc., Sigachi Industries Pvt. Ltd, Foodchem International Corporation, Quadra Chemicals, Maple Biotech Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., Accent Microcell Pvt. Ltd., RanQ, and Chemfield Cellulose.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up gradation, market expansion, and marketing tactics
  • The global microcrystalline cellulose market report caters to various stakeholders in this industry including investors, suppliers, Microcrystalline Cellulose manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Microcrystalline Cellulose market

Detailed Segmentation:

  • Global Microcrystalline Cellulose Market, By Source Type:
    • Wood Based
    • Non-wood Based
  • Global Microcrystalline Cellulose Market, By End Use Industry:
    • Pharmaceutical
    • Food & Beverages
    • Cosmetics & Personal Care
    • Others  
  • Global Microcrystalline Cellulose Market, By Region:
    • North America
      • By Country:
        • U.S
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • Germany
        • U.K
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East & Africa
      • By Country/Region:
        • Middle East
        • Africa
  • Company Profiles
    • Huzhou City Linghu Xinwang Chemical Co., Ltd..  
      • Company Overview
      • Product Portfolio
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Rayonier Advanced Materials
    • DFE Pharma
    • Mingtai Chemical Co., Ltd
    • JRS Pharma
    • Asahi Kasei Corporation
    • Dupont
    • Avantor Inc.
    • Sigachi Industries Pvt. Ltd
    • Foodchem International Corporation
    • Quadra Chemicals
    • Maple Biotech Pvt. Ltd.
    • Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
    • Accent Microcell Pvt. Ltd.
    • RanQ
    • Chemfield Cellulose.

 “*” marked represents similar segmentation in other categories in the respective section

Frequently Asked Questions

Global microcrystalline cellulose market was valued at around US$ 1,029.2 Million in 2021.
Increasing application of microcrystalline cellulose in various industries is a major factor propelling growth of the market.
Increasing disposable income in emerging economies is propelling growth of pharmaceuticals and food & beverages industry, which in turn boosting demand for microcrystalline cellulose.
Lack of universal directives pertaining to use and applications of microcrystalline cellulose is one of the major factors restraining growth of market. 
Major players operating in the market include Huzhou City Linghu Xinwang Chemical Co., Ltd., Rayonier Advanced Materials, DFE Pharma, Mingtai Chemical Co., Ltd, JRS Pharma, Asahi Kasei Corporation, Dupont, Avantor Inc., Sigachi Industries Pvt. Ltd, Foodchem International Corporation, Quadra Chemicals, Maple Biotech Pvt. Ltd., Anhui Sunhere Pharmaceutical Excipients Co., Ltd., Accent Microcell Pvt. Ltd., RanQ, and Chemfield Cellulose. 
The market is estimated to grow at around 6.7% CAGR in the forecast period (2022-2030).

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo